Trials that address multiple questions simultaneously using a master protocol can be operationally complicated. These complexities can be managed, even in studies used to support a marketing application.
Kent Buhler
Advertisement
Articles by Kent Buhler
Advertisement
Latest Updated Articles
How to Address—and Overcome—Operational Challenges in Master Protocol StudiesPublished: January 29th 2021 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Thermo Fisher, Lundbeck Announce New OpenAI Partnerships Advancing AI in Drug Development
2
Using Global Patient Data to Design Smarter, More Inclusive Clinical Trials
3
ACT Brief: AI Expands Global Site Leadership as Ozempic Shows Potential to Reverse Biological Age
4
Building Broader Investigator Networks to Advance Global Breast Cancer Research
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
